increased risk of kidney, pancreas and gastrointestinal problems Getty Images Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Nakajima T., Horiuchi M., Yamanaka H., Kizaki Z., Inoue F., Kodo N., Kinugasa A., Saheki T., Sawada T
Clarity Around Medication Types and Limitations Perfect Maximus Tribe includes a clear disclaimer: Compounded medications are not approved or evaluated for safety, efficacy, or quality by the FDA. Its clear and straightforward, but this level of disclosure is standard, not above and beyond
To integrate evidence across datasets, we performed a meta-analysis combining MR estimates from all cohorts, which allowed us to strengthen statistical power, assess effect consistency, and ensure the robustness of the observed associations across diverse populations
New research suggests that GLP 1 medications used for diabetes and weight loss may increase the risk of bone fractures and gout, adding to ongoing safety concerns that have already prompted product liability lawsuits against drug manufacturers
